Table 2.
ncRNA | Target gene | Effect on NLRP3 activation | Functions | Disease/research context | References |
---|---|---|---|---|---|
miR-22 | NLRP3 | Down |
•↓ EC apoptosis •↓ Pro-inflammatory cytokines •↑ Tube formation |
Coronary atherosclerosis | 135 |
miR-495 | NLRP3 | Down |
•↓ EC inflammation •↓ EC apoptosis •↑ EC proliferation |
Myocardial ischemia/reperfusion injury | 136 |
miR-15a | FOXO1 | Down | •↓ EC inflammation | Diabetic retinopathy | 137 |
miR-126 | HMGB1 | Down | •↓ EC inflammation | Diabetic retinopathy | 138 |
miR-590-3p | NLRP1, NOX4 | Down | •↓ EC inflammation, pyroptosis | Diabetic retinopathy | 139 |
miR-20a | TXNIP, TLR4 | Down |
•↓ EC inflammation •↓ ROS generation |
Atherosclerosis | 140 |
miR-30c-5p | FOXO3 | Down | •↓ EC inflammation, pyroptosis | Atherosclerosis | 141 |
miR-383-3p | IL1R2 | Down |
•↓ EC inflammation •↓ EC apoptosis •↑ Tube formation |
Coronary atherosclerosis | 142 |
miR-20b | TXNIP | Down | •↓ EC senescence | H2O2-induced EC senescence | 143 |
miR-101-3p | Bim | Down | •↓ EC apoptosis | Serum deprivation-induced EC apoptosis | 144 |
miR-200a-3p | Keap1, NLRP3 | Up | •↑ EC inflammation | Sepsis-induced brain injury | 145 |
miR-92a | SIRT1, KLF2, and KLF4 | Up |
•↑ Endothelial innate immunity •↓ NO bioavailability |
Atherosclerosis | 146 |
miR-125a-5p | TET2 | Up | •↑ EC inflammation, pyroptosis | Atherosclerosis | 147 |
LncRNA MALAT1 | miR-22 | Up | •↑ EC inflammation, pyroptosis | Atherosclerosis | 148 |
LncRNA MEG3 | miR-223 | Up | •↑ EC pyroptosis | Atherosclerosis | 149 |
LncRNA NEXN-AS1 | / | Down | •↓ EC pyroptosis | Atherosclerosis | 94 |
Hsa_circ_0068087 | miR-197 | Up |
•↑ EC inflammation •↑ Tube formation |
T2DM | 150 |